Crossmark

Total joint arthroplasty patients who experience the minimal clinically important difference for worsening (MCID-W) have higher revision rates at 1, 3, and 5 years postoperatively:

Crossref DOI link: https://doi.org/10.1007/s00402-025-06068-4

Published Online: 2025-10-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lim, Perry L.

Sauder, Nicholas

Peterson, Shian L.

Melnic, Christopher M.

Bedair, Hany S.
License Information

Text and Data Mining valid from 2025-10-21

Version of Record valid from 2025-10-21
More Information

Article History

Received: 28 April 2025

Accepted: 7 September 2025

First Online: 21 October 2025

Declarations

:

: Author Lim PL and Sauder N have no conflicts of interest to disclose. Author Peterson SL discloses being a member of the American Orthopaedic Association Critical Issues and Education Program Committee (AOA CIEP) as a DEI Liaison. Author Melnic CM is a speaker and paid consultant for Smith & Nephew and receives research support from Zimmer Biomet. Author Bedair HS receives royalties from and is a paid consultant for Exactech and Smith & Nephew, has stock options in DEF Medical and Osteon Holdings, receives research support from Zimmer Biomet, and receives royalties from Wolters Kluwer, Smith & Nephew and Exactech. These conflicts of interest are stated here but are unrelated to the present study.

Document is current

Any future updates will be listed below